NLRP3 and brain ischemia: In middle cerebral artery occlusion (MCAO) rat model, Arctigenin showed neuroprotective effects against cerebral ischemia via SIRT1-dependent inhibition of NLRP3 inflammasome (Zhang et al., 2017).